Ningshao Xia：Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
2024-04-10
Representative publications in 2023
2024-04-09
Ningshao Xia：Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
2024-04-09
Finding Germline Mutations(and drugs) that suppress cancer
2024-03-12
Ningshao Xia: Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
2023-09-22
Ningshao Xia: Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
